In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Neuronetics Inc (NASDAQ: STIM) closed at $1.34 in the last session, up 1.52% from day before closing price of $1.32. In other words, the price has increased by $1.52 from its previous closing price. On the day, 0.91 million shares were traded. STIM stock price reached its highest trading level at $1.395 during the session, while it also had its lowest trading level at $1.28.
Ratios:
We take a closer look at STIM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.09 and its Current Ratio is at 2.24. In the meantime, Its Debt-to-Equity ratio is 3.32 whereas as Long-Term Debt/Eq ratio is at 3.11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 08 ’25 when Madryn Asset Management, LP sold 3,500,000 shares for $3.72 per share. The transaction valued at 13,020,000 led to the insider holds 1,142,351 shares of the business.
MADRYN HEALTH PRTS II (CAY MAS bought 2,925,554 shares of STIM for $10,883,061 on Aug 08 ’25. On Aug 08 ’25, another insider, MADRYN HEALTH PARTNERS II, LP, who serves as the 10% Owner of the company, bought 192,806 shares for $3.72 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STIM now has a Market Capitalization of 91771136 and an Enterprise Value of 158553136. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.71 while its Price-to-Book (P/B) ratio in mrq is 3.35. Its current Enterprise Value per Revenue stands at 1.221 whereas that against EBITDA is -4.635.
Stock Price History:
The Beta on a monthly basis for STIM is 0.67, which has changed by 0.10924375 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, STIM has reached a high of $5.92, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is -44.22%, while the 200-Day Moving Average is calculated to be -62.28%.
Shares Statistics:
According to the various share statistics, STIM traded on average about 1.65M shares per day over the past 3-months and 2169510 shares per day over the past 10 days. A total of 68.44M shares are outstanding, with a floating share count of 37.25M. Insiders hold about 45.60% of the company’s shares, while institutions hold 31.14% stake in the company. Shares short for STIM as of 1763078400 were 6516778 with a Short Ratio of 3.96, compared to 1760486400 on 5807649. Therefore, it implies a Short% of Shares Outstanding of 6516778 and a Short% of Float of 16.409999.
Earnings Estimates
The market rating for Neuronetics Inc (STIM) is a result of the insights provided by 2.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.11 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.59 and -$0.61 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.46 and -$0.49.
Revenue Estimates
According to 3 analysts,. The current quarter’s revenue is expected to be $40.66M. It ranges from a high estimate of $40.99M to a low estimate of $40.3M. As of. The current estimate, Neuronetics Inc’s year-ago sales were $22.1MFor the next quarter, 3 analysts are estimating revenue of $37.22M. There is a high estimate of $38M for the next quarter, whereas the lowest estimate is $36.45M.
A total of 3 analysts have provided revenue estimates for STIM’s current fiscal year. The highest revenue estimate was $148.55M, while the lowest revenue estimate was $147.7M, resulting in an average revenue estimate of $148.08M. In the same quarter a year ago, actual revenue was $74.5MBased on 3 analysts’ estimates, the company’s revenue will be $164.15M in the next fiscal year. The high estimate is $164.65M and the low estimate is $163.8M.
